Nuveen Asset Management, LLC Sage Therapeutics, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 142,694 shares of SAGE stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142,694
Previous 142,694
-0.0%
Holding current value
$1.24 Million
Previous $1.03 Million
24.71%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding SAGE
# of Institutions
77Shares Held
17.5MCall Options Held
282KPut Options Held
320K-
Black Rock Inc. New York, NY5.22MShares$45.3 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8599KShares$5.2 Million0.03% of portfolio
-
Jacobs Levy Equity Management, Inc Florham Park, NJ582KShares$5.05 Million0.02% of portfolio
-
Credit Suisse Ag Zurich, V8103KShares$897,5640.0% of portfolio
-
Equitec Proprietary Markets, LLC63.9KShares$554,6520.57% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $516M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...